Kristin Higgins, MD

Kristin Higgins, M.D., is chief clinical officer for City of Hope® Cancer Center Atlanta, where she oversees clinical care and hospital operations. Prior to joining City of Hope, Dr. Higgins spent 13 years at Emory University, where she built an international reputation as a lung cancer expert, developing numerous clinical trials focused on combination radiotherapy treatments for patients with non-small cell and small cell lung cancer. Her many research leadership positions include serving as principal investigator of NRG/Alliance LU005, an international, phase 3 clinical trial investigating the use of immunotherapy alongside standard chemoradiation for lung cancer patients.

After earning her medical degree at Tulane University School of Medicine in New Orleans, Dr. Higgins completed an internship in internal medicine and a residency in radiation oncology, both at Duke University Medical Center in North Carolina, which named her chief resident. She then moved to Atlanta, where she spent 13 years at Emory University, earning an international reputation for her expertise in lung cancer.

Dr. Higgins is a member of multiple boards and committees in the lung cancer advocacy community, including the National Lung Cancer Roundtable Survivorship Task Group and the NRG Oncology Lung Cancer Core Committee, and the board of directors for NRG Oncology and RTOG Foundation. She has also co-chaired the World Conference on Lung Cancer and is the author of more than 100 peer-reviewed publications.

Disclosures: